ITGAV and pancreatic adenocarcinoma: Survival analysis revealed that patients with high ITGAV expression had a worse DFS than those with low ITGAV expression did, indicating that ITGAV may serve as a negative prognostic factor in PAAD (Fig. 7B-D).